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While the organization of neurological soft signs (NSS) in schizo-
phrenia into Sensory integration, Motor coordination, and Motor
sequencing, is functionally ‘meaningful’, it has not been conﬁrmed
by empirical methods such as factor analysis. Data on the
exploratory factor analysis of the Neurological Evaluation scale in
Black Africans with ﬁrst episode schizophrenia are presented in
this report. Data on the conﬁrmatory factor structure of NSS in this
population as well as their interpretation can be found in the work
by Ojagbemi et al. (2015) [7].
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A. Ojagbemi et al. / Data in Brief 6 (2016) 471–475472xperimental
factorsMedication naïve or minimally treated patients with ﬁrst episode schizophreniaxperimental
featuresA wash-out period of one week was allowed for 5 participants (6% of the sample)
who had a lifetime exposure to oral antipsychotics of less than 4 weeks.ata source
locationIbadan, South-Western Nigeriaata accessibility Analyzed data are supplied with this articleValue of the data
 First factor analysis of Neurological Soft Signs (NSS) in Black Africans with schizophrenia.
 Large sample of medication naïve or minimally treated patients with ﬁrst episode schizophrenia.
 Data provides the possibility for designing a shorter version of the Neurological evaluation
scale (NES).
 Data also provides preliminary information about the possibility of unique NSS categories in
ethnically and racially distinct populations of patients with schizophrenia.1. Introductory remarks
Neurological soft signs (NSS) are an important subset in the heterogeneous expression of schi-
zophrenia. This is because of their potential as easy-to-measure vulnerability indicators of the dis-
ease. The most convincing evidence for this assertion comes from data derived from ﬁrst episode
patients with schizophrenia, or those without prior exposure to antipsychotic treatments [3,8,9].
Some evidence have also come from data on ﬁrst degree relatives of schizophrenia patients [5,6], as
well as patients with schizophrenia spectrum disorders [2,4].
Factor analysis is a technique used for the reduction of datasets to underlying meaningful sub-sets
for the identiﬁcation of key variables among many observed variables. Globally, existing evidence on
the factor structure of NSS in schizophrenia has been mostly based on populations outside the African
continent [10,11], or on samples comprising of Mixed population of Caucasians and other races [3].
Data on the ﬁrst factor analysis of NSS in antipsychotic naive or minimally treated patients with ﬁrst
episode schizophrenia are presented here.
Data on the conﬁrmatory factor structure of NSS in this population as well as their interpretation
can be found in the work by Ojagbemi et al. [7].2. Data
This data is derived from the neurological examination of 84 unmedicated or minimally treated
patients with ﬁrst episode schizophrenia diagnosed according to criteria in the fourth revision of the
diagnostic and statistical manual of mental disorders (DSM IV). The data presented in three parts. The
ﬁrst part (see Table 1) contains the proportion of participants with abnormalities of the NSS captured
in the Neurological evaluation scale (NES). Also included in Table 1 is the mean and standard
deviation (SD) of the severity of individual NSS abnormalities, as well as the overall severity of NSS in
the sample. The second part of the data contains the factor loadings, the total variance contributed by
each factor loading, as well as their eigenvalues (see Table 2). The mean and SD of the severity of each
factor category is also presented. Lastly, the presented data contains the ﬁnal 3 (correlated) factor
structure of NSS in the sample (Fig. 1).
Table 2
Factor structure of the NES Items.
NES Items Factors
1 2 3 4
Audiovisual integration 0.6179 0.3813 0.1862 0.0691
Fist-edge-palm 0.8403 0.0635 0.0507 0.0175
Rythm tapping 0.6279 0.4463 0.3077 0.0460
Extinction 0.6112 0.2675 0.2758 0.2573
Right/left confusion 0.5355 0.1595 0.3305 0.0876
Synkinesis 0.0250 0.7128 0.2598 0.2451
Convergence 0.1743 0.7300 0.0335 0.0300
Gaze impersistence 0.2665 0.6417 0.1330 0.1574
Tandem Walk 0.1647 0.0166 0.6718 0.0700
Adventitious ﬂow 0.1534 0.0558 0.7188 0.0706
Graphaesthesia 0.0702 0.3899 0.5443 0.2191
Stereognosis 0.2321 0.1389 0.0706 0.8562
Memory 0.4459 0.1318 0.3792 0.3235
Rapid alternating
movements
0.3139 0.4897 0.1705 0.3702
Finger/thumb opposition 0.4290 0.4148 0.2145 0.3418
Mirror movement 0.3394 0.3911 0.1305 0.3925
Finger to nose test 0.0312 0.1174 0.1409 0.0929
Grasp reﬂex 0.3895 0.2048 0.1155 0.6424
Explained variance (%) 18.1 15.5 10.4 10.1
Eigenvalues 6.5 1.5 1.3 1.2
Severity. Mean (SD) 6.44 (3.27) 2.38 (2.02) 2.00 (1.56) 0.51 (0.78)
Table 1
Prevalence and mean Severity scores of NES Items.
NES Items Number Percent Mean Standard
deviation
Audiovisual integration 45 53.6 1.21 0.91
Fist-edge-palm 60 71.4 1.56 0.77
Rythm tapping 47 56.0 1.29 0.87
Extinction 32 38.1 0.91 0.93
Right/left confusion 41 48.1 1.19 0.87
Synkinesis 22 26.2 0.70 0.86
Convergence 22 26.2 0.75 0.85
Gaze impersistence 30 35.7 0.93 0.89
Tandem Walk 14 16.7 0.50 0.77
Adventitious ﬂow 5 6.0 0.24 0.55
Graphaesthesia 44 52.4 1.26 0.85
Stereognosis 15 17.9 0.51 0.78
Memory 63 75.0 1.30 0.82
Rapid alternating
movements
25 29.8 0.77 0.88
Finger/thumb opposition 30 35.7 0.87 0.92
Mirror movement 16 19.0 0.51 0.80
Finger to nose test 15 17.9 0.57 0.78
Grasp reﬂex 21 25.0 0.50 0.87
Total NES score 84 100 11.33 5.85
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Patients examined for the purpose of the present data were aged between 16 and 45 years. They
presented for biomedical treatment for the ﬁrst time at the psychiatric units of two general hospitals
Fig. 1. The overall factor structure of neurological soft signs in Nigerians with ﬁrst episode schizophrenia. PMS- Perceptual and
motor sequencing, EYE- Eye movement, MCG- Motor co-ordination and graphaesthesia.
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2009 and June, 2011 (about 26 months). Patients were from the Yoruba ethnic group and were
resident within and around Ibadan. Thus, the sample for the present data was racially homogenous.
Patients were approached after they had been seen by the clinician, usually a consultant psy-
chiatrist or a trainee psychiatrist, who was responsible for their routine clinical assessment at pre-
sentation. Only those who were assessed by the clinician to have a psychotic illness were approached
for possible participation in the study. Written informed consent was obtained from all participants,
and/or their guardians after the data collection procedure was explained to them in either English or
the local Yoruba language. Neurological soft signs (NSS) in a total of 84 patients with conﬁrmed
diagnosis of schizophrenia (81.0%), schizophreniform disorder (17.9%), and schizoaffective disorder
(1.2%) according to criteria in the DSM IV were cross-sectionally measured before antipsychotic
medications were prescribed.
The NSS were assessed using the NES [1]. The NES includes tests such as tandem walk, rapid
alternation movements, ﬁnger to thumb opposition, the ﬁnger-to-nose test, audiovisual integration,
stereognosis, graphesthesia, extinction, and right to left confusion, ﬁrst-ring test, the ﬁrst-edge-palm
test, the Ozeretski test, and rhythmic tapping test. The other signs assessed by the NES include cer-
ebral dominance, short-term memory, frontal release signs and eye movement. The NES items are
scored with reference to the descriptive anchors provided on a three-point scale (no abnormality¼0;
mild, but deﬁnite impairment¼1; marked impairment¼2) with the exception of ‘suck’ and ‘snout’
reﬂexes which are scored 0 or 2. A neurological abnormality was deﬁned as the rating of 2 on any
1 item on the NES. The tests were administered by a psychiatrist who had been trained in the use of
the NES. Each item was assessed according to a ﬁxed order.
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the entire sample. Items testing for cerebral dominance were excluded from the analyses. Factors
obtained following initial maximum likelihood exploration were further rotated using the varimax
procedure. Factors are recorded when they have eigenvalues greater than unity, and when they
contribute at least 10% to the cumulative variance [11].Acknowledgements
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